Fresenius Medical Care AG & Co. KGaA 30.09.2014 17:54 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On 30 September 2014, we have received the following notification from BlackRock Investment Management (UK) Limited: Following a review, conducted in close collaboration with the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin), of the way BlackRock has interpreted its voting rights disclosure obligations under German law, BlackRock entities are filing today a statement representing their holdings as at the settlement date of 25 September 2014 in Fresenius Medical Care AG & Co. KGaA. The statement does not reflect a change in BlackRock's current holdings of voting rights. The statement simply updates information currently in the market regarding BlackRock's holdings in Fresenius Medical Care AG & Co. KGaA. Further, the statement does not signify any change in investment strategies pursued. Also, BlackRock issues a press release detailing the BlackRock group entities and their respective voting rights applicable to Fresenius Medical Care AG & Co. KGaA and other relevant German issuers on http://www.blackrock.com/corporate/en-gb/news-and-insights/press-releases and on Bloomberg. VOTING RIGHTS DISCLOSURE 1. BlackRock, lnc. Section 21, 22 BlackRock, lnc., New York, NY, U.S.A., hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of Fresenius Medical Care AG & Co. KGaA (ISIN DE0005785802) on 25 September 2014 amounts to 4.11% (this corresponds to 12,750,189 out of a total of 310,275,817 voting rights (the 'Total Voting Rights')). 1.93% of the Total Voting Rights (this corresponds to 5,982,555 voting rights) are to be attributed to BlackRock, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG. 1.86% of the Total Voting Rights (this corresponds to 5,764,152 voting rights) are to be attributed to BlackRock, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.26% of the Total Voting Rights (this corresponds to 807,001 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.06% of the Total Voting Rights (this corresponds to 196,481 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 2 in connection with sentence 2 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 2. BlackRock Holdco 2, lnc. Section 21, 22 BlackRock Holdco 2, lnc., Wilmington, DE, U.S.A., hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of Fresenius Medical Care AG & Co. KGaA (ISIN DE0005785802) on 25 September 2014 amounts to 4.05% (this corresponds to 12,554,058 out of a total of 310,275,817 voting rights (the 'Total Voting Rights')). 1.93% of the Total Voting Rights (this corresponds to 5,982,555 voting rights) are to be attributed to BlackRock Holdco 2, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG. 1.79% of the Total Voting Rights (this corresponds to 5,568,021 voting rights) are to be attributed to BlackRock Holdco 2, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.26% of the Total Voting Rights (this corresponds to 807,001 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.06% of the Total Voting Rights (this corresponds to 196,481 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 2 in connection with sentence 2 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 3. BlackRock Financial Management, lnc. Section 21, 22 BlackRock Financial Management, lnc., New York, NY, U.S.A., hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of Fresenius Medical Care AG & Co. KGaA (ISIN DE0005785802) on 25 September 2014 amounts to 4.04% (this corresponds to 12,537,228 out of a total of 310,275,817 voting rights (the 'Total Voting Rights')). 1.93% of the Total Voting Rights (this corresponds to 5,982,555 voting rights) are to be attributed to BlackRock Financial Management, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG. 0.002% of the Total Voting Rights (this corresponds to 5,742 voting rights) are to be attributed to BlackRock Financial Management, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 WpHG. 1.79% of the Total Voting Rights (this corresponds to 5,545,449 voting rights) are to be attributed to BlackRock Financial Management, lnc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.26% of the Total Voting Rights (this corresponds to 807,001 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.06% of the Total Voting Rights (this corresponds to 196,481 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 2 in connection with sentence 2 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 30.09.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Fresenius Medical Care AG & Co. KGaA Else-Kröner-StraÃe 1 61352 Bad Homburg Germany Internet: www.fmc-ag.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: Fresenius Medical Care AG & Co. KGaA: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG